Table 1.
Variable | No delay (Diagnostic follow- up ≤60 days) (%) n=348 |
Diagnostic delay >60 days (%) n=307 |
P-value |
---|---|---|---|
Age at HCC diagnosis | - | - | 0.84 |
<50 years | 10 (2.9) | 6 (2.0) | |
50-64 years | 247 (71.0) | 221 (72.0) | |
65-79 years | 70 (20.1) | 64 (20.9) | |
≥80 years | 21 (6.0) | 16 (5.2) | |
Year of HCC diagnosis | - | - | <0.001 |
2006 | 67 (19.3) | 16 (5.3) | |
2007 | 53 (15.2) | 49 (16.2) | |
2008 | 80 (23.0) | 63 (20.9) | |
2009 | 80 (23.0) | 86 (28.5) | |
2010 | 59 (17.0) | 68 (22.5) | |
2011 | 9 (2.6) | 20 (6.6) | |
Race/ethnicity | - | - | 0.39 |
White | 203 (58.3) | 174 (56.7) | |
Black | 94 (27.0) | 78 (25.4) | |
Hispanic | 42 (12.1) | 50 (16.3) | |
Other | 9 (2.6) | 5 (1.6) | |
VA treatment facility location | - | - | 0.79 |
Central | 57 (16.4) | 50 (16.3) | |
East | 77 (22.1) | 78 (25.4) | |
South | 134 (38.5) | 114 (37.1) | |
West | 80 (23.0) | 65 (21.2) | |
Hepatitis B (HBV) | 20 (5.8) | 13 (4.2) | 0.40 |
Hepatitis C (HCV) | 258 (74.1) | 240 (78.2) | 0.23 |
Diabetes mellitus | 126 (36.2) | 120 (39.1) | 0.45 |
History of alcohol or drug abuse | 183 (52.6) | 174 (56.7) | 0.29 |
Liver disease severity | - | - | <0.001 |
Child-Pugh class A | 101 (29.8) | 128 (44.6) | |
Child-Pugh class B | 178 (52.5) | 132 (46.0) | |
Child-Pugh class C | 60 (17.7) | 27 (9.4) | |
Barcelona staging | - | - | <0.001 |
A | 37 (11.1) | 71 (25.7) | |
B | 71 (21.3) | 77 (27.9) | |
C | 138 (41.3) | 91 (33.0) | |
D | 88 (26.4) | 37 (13.4) | |
Lesion size | - | - | <0.001 |
<1 cm | 20 (5.8) | 99 (32.3) | |
1-2 cm | 183 (52.6) | 182 (59.3) | |
>2 cm | 145 (41.7) | 26 (15.2) | |
Deyo-Charlson Comorbidity Index | - | - | 0.002 |
0 | 60 (17.5) | 29 (9.6) | |
1 | 145 (42.3) | 118 (38.9) | |
≥2 | 138 (40.2) | 156 (51.5) |